Climacteric

Papers
(The median citation count of Climacteric is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Low thrombin generation in postmenopausal women using estetrol127
Safety and acceptability of intravaginal rings releasing estradiol and progesterone80
Peer reviewers for Climacteric in 202449
Expanding knowledge across medical specialties in menopause research and practice: why it is so important for women’s health37
Effects of jazz dance and concurrent training on physical variables in postmenopausal women35
Scientific insights into brain fog during the menopausal transition34
Pregnancy-associated risk factors for future cardiovascular disease – early prevention strategies warranted33
Variations in the prevalence of premature and early menopause in low and middle-income regions: a cross-sectional study29
Association of bilateral oophorectomy and menopause hormone therapy with mild cognitive impairment: the REDLINC X study26
Recent advances in the management of postmenopausal women with non-atypical endometrial hyperplasia25
Peer reviewers for Climacteric in 202224
Update on bone health: the International Menopause Society White Paper 202123
Association between coronary artery vitamin D receptor expression and select systemic risks factors for coronary artery atherosclerosis22
Pharmacokinetics, safety and preliminary pharmacodynamic evaluation of DARE-VVA1: a soft gelatin capsule containing tamoxifen for the treatment of vulvovaginal atrophy22
Influence of estradiol deficiency on the mineralocorticoid receptor response in postmenopausal women: a cross-sectional study22
Relationship between menopausal hormone therapy and incidence of fractures in postmenopausal women21
The musculoskeletal syndrome of menopause20
John Studd (4th March 1940–17th August 2021)18
Effect of estrogen on vaginal complications of pessary use: a systematic review and meta-analysis17
Quo vadis?17
Satisfaction and medication adherence in women with vulvovaginal atrophy: the CRETA16
Ultra-low-dose estradiol and dydrogesterone for treatment of vasomotor symptoms in Europe and China15
Association of serum uric acid with handgrip strength and dynapenia in postmenopausal women15
Does climacteric status impact regulation of the autonomic nervous system at the age of 46 years?15
Menopausal symptoms among perimenopausal women in rural Turkey: a cross-sectional study14
Good night and good luck14
The impact of ovarian aging on muscle strength and life quality in various reproductive aging stages14
Ellen Theresia Maria Laan (April 3, 1962–January 22, 2022)13
Menopausal hormone therapy: what are the problems in the perception of Chinese physicians?13
A bibliometric analysis of primary ovarian insufficiency from 2010 to 202013
Osteoanabolic therapy for osteoporosis in women12
Resveratrol promotes bone mass in ovariectomized rats and the SIRT1 rs7896005 SNP is associated with bone mass in women during perimenopause and early postmenopause12
The LADY study: epidemiological characteristics of prevalent and new genitourinary syndrome of menopause cases in Greece12
What is the evidence for the effect of physical exercise on bone health in menopausal women? An umbrella systematic review12
Not just sex: other roles for testosterone in women12
VDRgeneApaI polymorphism and risk of postmenopausal osteoporosis: a meta-analysis from 22 studies12
Thank you11
Impact of non-hip fractures in elderly women: a narrative review11
The next chapter11
Systemic hormone therapy after breast and gynecological cancers: an Italian expert group consensus opinion11
NK3 receptor antagonist alters the centrally controlled perception of menopausal flushing – a pilot study11
Low-dose and ultra-low-dose estradiol and dydrogesterone in postmenopause: an analysis by body mass index11
Menopausal age and cardiovascular disease risk in American women: evidence from the National Health and Nutrition Examination Survey11
Reproductive milestones across the lifespan and cardiovascular disease risk in women11
Factors influencing seogeulpeum among middle-aged Korean women11
Progesterone and not estrogens or androgens causes breast cancer11
Impact of overweight and obesity in postmenopausal women11
POESIT recommendations on management of body-identical hormones in menopausal symptoms10
Early decrease in lean mass and bone mass in postmenopausal women: a cross-sectional study10
Postmenopausal women’s adherence to pelvic floor muscle exercises over 2 years10
Management of obesity in menopause10
Effects of exercise on vasomotor symptoms in menopausal women: a systematic review and meta-analysis10
COVID-19-related premature ovarian insufficiency: case report and literature review10
Are we assessing genitourinary syndrome of menopause properly?9
Menopausal hormone therapy: why we should no longer be afraid of the breast cancer risk9
The yin and yang of GSM and low sexual desire9
Estrogen as a guardian of auditory health: Tsp1–CD47 axis regulation and noise-induced hearing loss9
Management of menopause: a survey of physicians from the Middle East and Africa9
Hormone therapy for postmenopausal osteoporosis management9
FNDC5/Irisin polymorphisms are associated with osteopenia in postmenopausal Mayan-Mestizo women9
Premature ovarian insufficiency: addressing the most controversial issues8
Safety of prasterone in breast cancer survivors treated with aromatase inhibitors: the VIBRA pilot study8
Neuroprotective effect of hormone replacement therapy: a review of the literature8
Menopause hormone treatment after cancer8
Use of aromatase inhibitors in menopausal deep endometriosis: a case report and literature review8
Corneal thickness, contrast sensitivity and binocular vision in menopausal and non-menopausal women7
First live birth in China after cryopreserved ovarian tissue transplantation to prevent premature ovarian insufficiency7
A research primer for studies of cognitive changes across the menopause transition7
Selective estrogen receptor modulators and bone health7
Higher testosterone is associated with higher HDL-cholesterol and lower triglyceride concentrations in older women: an observational study7
Is it possible that menopause is associated with telomere length? Findings of an integrative review7
Effect of hormone therapy on personality traits: preliminary evidence in older men and women7
Therapeutic effects of curculigoside on cyclophosphamide-induced premature ovarian failure in mice7
Prevalence, impact and management of postmenopausal symptoms among postmenopausal women in Rwanda7
Psychosomatic and medical experiences of menopause in Chinese women: a social media study7
First pregnancy in China after ovarian tissue transplantation to prevent premature ovarian insufficiency7
Reflections7
In search of a well-balanced narrative of the menopause momentum7
The impact of menopause education on quality of life among menopausal women: a systematic review with meta-analysis6
Bone-friendly lifestyle and the role of calcium or vitamin D supplementation6
Pulmonary embolism in menopausal hormone therapy: a population-based register study6
Testosterone for women: certainties and uncertainties6
The mediating role of socioeconomic status on the relationship between pregnancy history and later-life cognition6
Acupuncture and Chinese herbal medicine for menopausal mood disorder: a randomized controlled trial6
Does the environment affect menopause? A review of the effects of endocrine disrupting chemicals on menopause6
Using menopausal hormone therapy to prevent fracture recurrence in older women: is it time to change our opinion?6
Peer reviewers for Climacteric in 20236
Menopausal hormonal therapy in surgically menopausal women with underlying endometriosis5
Medical management of obesity: unlocking the potential5
Increasing climacteric symptoms in untreated perimenopausal Finnish women: a 10-year cohort study5
Hysteroscopic laser ablation of symptomatic uterine fibroids: insights from a prospective study5
The prevalence and severity of vasomotor and sexual symptoms among refugee women in Australia5
The effects of hormone replacement therapy on the microbiomes of postmenopausal women5
Analysis of multimorbidity patterns in perimenopausal women based on medical examination data5
BRCA carriers after risk-reducing bilateral salpingo-oophorectomy: menopausal hormone therapy knowledge gaps, and the impact of physicians’ recommendations5
Updated premature ovarian insufficiency guideline5
Endocrine consequences of breast cancer therapy and survivorship5
Effect of resistance training combined with β-glucan ingestion on bone of ovariectomized mice5
Relation between blood pressure and genito-urinary symptoms in the years across the menopausal age5
Resistance training effects on healthy postmenopausal women: a systematic review with meta-analysis5
Vaginal oxygen plus hyaluronic acid on genito-urinary symptoms of breast cancer survivors5
Medical treatment of osteoporosis5
Effects of resistance training on quality of life in postmenopausal women with vasomotor symptoms4
Cardiovascular risk assessment in women: which women are suited for menopausal hormone therapy?4
Polycystic ovary syndrome: associations with cardiovascular disease4
Transgender health and the impact of aging and menopause4
Impact of vaginal estriol on serum hormone levels: a systematic review4
Effects of ospemifene on overactive bladder in postmenopausal women with vulvovaginal atrophy4
Primary choice of estrogen and progestogen as components for HRT: a clinical pharmacological view4
Genitourinary syndrome of menopause: a multicenter study from the Indian Midlife Registry4
Ischemia but no obstructive coronary artery disease: more than meets the eye4
Unraveling sleep quality in menopausal women: objective assessments and self-reported experiences – a mini-review4
From waste to wellness – what women want: insights into patient perspectives on topical vaginal estrogen applicators and environmental considerations4
Authorization of anastrazole to prevent breast cancer in postmenopausal women: a bad idea4
Correction4
The promotion of menopausal hormone therapy might be determined by the attitude of health-care professionals4
Menopausal hormone therapy and coronary heart disease: the roller-coaster history4
Brain fog in menopause: a health-care professional’s guide for decision-making and counseling on cognition4
Heart matters: the unique landscape of cardiovascular health in women4
Use of an estradiol transdermal spray in women with menopausal symptoms: a non-interventional study4
Ovarian tissue cryopreservation and transplantation – first baby in China4
Progress in understanding and management of premature ovarian insufficiency4
Statement of Retraction: Role of topical oxytocin in improving vaginal atrophy in postmenopausal women: a randomized, controlled trial4
Translation and validation of the Depression Anxiety Stress Scales for menopausal women in Indonesia4
Impacts of menopause hormone therapy on mood disorders among postmenopausal women4
A pas de deux of osteoporosis and sarcopenia: osteosarcopenia4
Gender-affirming hormone therapy and cardiovascular health in transgender adults4
Evidence-based guideline: premature ovarian insufficiency 3
Clinical practice: guidelines, position statements, recommendations and tool kits3
Obesity indices and cardiometabolic diseases in postmenopausal women in Ilorin, Nigeria3
Correction3
Sequential treatment in vulvovaginal atrophy3
Vulvodynia – an evolving disease3
Physician–patient alignment on menopause-associated symptom burden: real-world evidence from the USA and Europe3
Non-hormonal treatments for managing vulvovaginal atrophy/genitourinary syndrome of menopause3
Use of a vaginal CO2 laser for the management of genitourinary syndrome of menopause in gynecological cancer survivors: a systematic review3
Cardiovascular disease in women: take it to heart3
Menopause and diabetes3
The WHO claims estrogens are ‘carcinogenic’: is this true?3
Associations between blood sex hormones, cognitive decline and incident dementia in community-dwelling older Australian women: a prospective cohort study3
Presidential reflections: how we got here, where we might go3
Hormone replacement therapy and myocardial infarction and stroke in postmenopausal Korean women3
Menopause status and climacteric symptoms in a birth cohort of mid-life New Zealand women3
Effects of a therapeutic lifestyle modification intervention on health-related quality of life and sexual functioning and cardiometabolic health in perimenopausal Chinese women: a randomized controlle3
Urologic view in the management of genitourinary syndrome of menopause3
Flaxseed and mulberry extract improve trabecular bone quality in estrogen-deficient rats3
An interprofessional clinic for adults with Turner syndrome: the patient perspective3
Fezolinetant for VMS: a balanced view on efficacy and safety needed3
Challenges in setting up menopause care clinics in the Philippines3
Treating genitourinary syndrome of menopause in breast cancer survivors: main challenges and promising strategies3
Treatment of women with BRCA mutation3
Understanding of and clinical approach to cardiometabolic transition at the menopause3
Limitations in functioning in climacteric syndrome: a systematic literature review using the ICF3
Vulvovaginal atrophy management with a laser: the placebo effect or the conditioning Pavlov reflex3
The rs2018736 fibulin-5 polymorphism as a determinant for pelvic organ prolapse: a case–control study3
Fezolinetant for VMS: a balanced view on efficacy and safety needed – author’s reply2
Vaginal microbiome of women with premature ovarian insufficiency: a descriptive cross-sectional study2
Quality of life in menopausal women in the workplace – a systematic review2
Mental health during the COVID-19 pandemic: the importance of social support in midlife women2
Expert opinion on the treatment of vulvovaginal atrophy with ospemifene based on new evidence2
Associations of fat mass index with hot flashes and lean mass index with insomnia in middle-aged women2
Ultra-low-dose estradiol and dydrogesterone: a phase III study for vasomotor symptoms in China2
Global view of vasomotor symptoms and sleep disturbance in menopause: a systematic review2
Perimenopausal combined hormonal contraception: focus on sexual function2
Isoflavones obtained from red clover improve both dyslipidemia and menopausal symptoms in menopausal women: a prospective randomized placebo-controlled trial2
Testosterone and the heart: friend or foe?2
Use of MHT in women with cardiovascular disease: a systematic review and meta-analysis2
Lichen sclerosus of the vulva2
Fezolinetant for the treatment of vasomotor symptoms associated with menopause: a meta-analysis2
Efficacy of intradermal hyaluronic acid plus polynucleotides in vulvovaginal atrophy: a pilot study2
The role of estrogens in osteosarcopenia: from biology to potential dual therapeutic effects2
Correction2
Breast cancer therapy and bone2
Vaginal laser therapy for GSM/VVA: where we stand now – a review by the EUGA Working Group on Laser2
Alterations of regional homogeneity in perimenopause: a resting-state functional MRI study2
Correction2
Psychometric properties of the French Hot Flash Related Daily Interference Scale (HFRDIS)2
Telemedicine and women’s health2
The influence of HIV on body composition and its relationship with physical function in mid-life women: a cross-sectional study from Zimbabwe2
The impact of micronized progesterone on cardiovascular events – a systematic review2
Arthralgia in midlife Singaporean women: the Integrated Women’s Health Program (IWHP)2
Peer review: improving feedback2
Risk of endometrial malignancy in women treated for breast cancer: the BLUSH prediction model – evidence from a comprehensive multicentric retrospective cohort study2
Premature ovarian insufficiency and the risk of breast cancer: author reply2
Closing the gap: cardiovascular disease in women2
Impact of Global Consensus Statement on compliance with hormonal therapy for surgical menopause2
Cut-off point development for the Everyday Memory Questionnaire – Revised in perimenopausal women2
Acupuncture and Chinese herbal medicine for menopausal mood disorder: a randomized controlled trial [Letter]2
Bone health 2022: an update2
0.02701997756958